• Aji Bio-Pharma, DNDi Enter Strategic Supply Pact contractpharma
    October 09, 2020
    Aji Bio-Pharma will manufacture CpG-D35, a class of CpG oligonucleotides to be used in the treatment of cutaneous leishmaniasis infections.
  • Sanofi, DNDi seek EMA review for sleeping sickness drug pharmatimes
    February 02, 2018
    Sanofi has asked European regulators to review an experimental medicine being developed in partnership with the Drugs for Neglected Disease initiative (DNDi) for sleeping sickness, which is endemic in Africa.
PharmaSources Customer Service